BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Pharm Country

  Physicians’ Education Resource® Announces Section Moderators for the 1st Annual International Congress on the Future of Neurology™

  Physicians’ Education Resource® (PER®), a worldwide leading resource for continuing medical education (CME), has named the section moderators for the 1st Annual International Congress on the Future of Neurology™.

  August 22, 2019

   · 

  3 min read
• MDClone, Developer of First Healthcare Synthetic Data Engine, Raises $26 Million

  MDClone announced today the closing of a $26 million Series B funding round led by health-tech venture capital fund aMoon, with additional funding from existing investors OrbiMed Israel Partners and Lightspeed Venture Partners.

  August 22, 2019

   · 

  4 min read
• Business

  Infinity Pharmaceuticals Announces Transition of Samuel Agresta, M.D., from Chief Medical Officer to Board of Directors

  Samuel Agresta, M.D., will transition from his role as Chief Medical Officer to Infinity’s Board of Directors and Research and Development Committee.

  August 22, 2019

   · 

  4 min read
• Pharm Country

  Imbrium Therapeutics L.P. and SpineThera Announce Issuance of U.S. Patent Covering Composition of Matter Protection for SX600, a Non-Opioid Product in Development for Epidural Steroid Injection for the Treatment of Low Back Pain

  Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Purdue Pharma L.P., in conjunction with SpineThera, Inc., today announced issuance of U.S. Patent No. 10,350,222 from the United States Patent and Trademark Office.

  August 22, 2019

   · 

  3 min read
• Policy

  Information Update - Multiple unauthorized sexual enhancement products seized from “For Lovers Only” in Saskatoon, Saskatchewan, may pose serious health risks

  Health Canada is advising Canadians that the following products may pose serious health risks.

  August 22, 2019

   · 

  3 min read
• Policy

  Fortis College In Cutler Bay Receives ACEN Accreditation

  In order to receive accreditation, institutions must apply for and undergo a comprehensive review process that evaluates the quality and effectiveness of its nursing education program on multiple levels.

  August 22, 2019

   · 

  2 min read
• Business

  /C O R R E C T I O N -- EW Healthcare Partners/

  EW Healthcare Partners announced it raised over $745 million in EW Healthcare Partners Fund 2, L.P., the Firm’s second dedicated growth equity fund.

  August 22, 2019

   · 

  4 min read
• Biotech Bay

  Five Prime Therapeutics to Present at Upcoming Healthcare Conference - Aug. 22, 2019

  Five Prime Therapeutics, Inc. announced that Aron Knickerbocker, Chief Executive Officer, is scheduled to present at the following healthcare conference

  August 22, 2019

   · 

  1 min read
• Job Trends

  Fuse Medical Announces Launch of Sterizo Total Knee Replacement System

  Fuse Medical, Inc., (OTCPK: FZMD), an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the launch of the Sterizo Total Knee Replacement System, the latest addition to a comprehensive line of orthopedic product offerings.

  August 22, 2019

   · 

  3 min read
• Job Trends

  Clovis Oncology Announces Exercise by Initial Purchasers of Their Option to Purchase an Additional $13.0 Million Aggregate Principal Amount of the Company’s 4.50% Convertible Senior Notes Due 2024

  Following the closing, there will be a total of $263.0 million aggregate principal amount of the notes outstanding.

  August 22, 2019

   · 

  3 min read